Ameritas Investment Partners, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.84 Billion
- Q2 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,317 shares of ARCT stock, worth $53,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,317
Previous 2,317
-0.0%
Holding current value
$53,777
Previous $78,000
28.21%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARCT
# of Institutions
186Shares Held
25.9MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$109 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$61.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$45.6 Million0.44% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$36.3 Million0.03% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$36.3 Million0.44% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $617M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...